[go: up one dir, main page]

HUP9903541A3 - Nasal administration of desmopressin - Google Patents

Nasal administration of desmopressin

Info

Publication number
HUP9903541A3
HUP9903541A3 HU9903541A HUP9903541A HUP9903541A3 HU P9903541 A3 HUP9903541 A3 HU P9903541A3 HU 9903541 A HU9903541 A HU 9903541A HU P9903541 A HUP9903541 A HU P9903541A HU P9903541 A3 HUP9903541 A3 HU P9903541A3
Authority
HU
Hungary
Prior art keywords
desmopressin
nasal administration
nasal
administration
Prior art date
Application number
HU9903541A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HUP9903541A2 publication Critical patent/HUP9903541A2/hu
Publication of HUP9903541A3 publication Critical patent/HUP9903541A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9903541A 1996-06-20 1997-06-10 Nasal administration of desmopressin HUP9903541A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/667,047 US5763398A (en) 1996-06-20 1996-06-20 Nasal administration of desmopressin

Publications (2)

Publication Number Publication Date
HUP9903541A2 HUP9903541A2 (hu) 2000-04-28
HUP9903541A3 true HUP9903541A3 (en) 2000-10-30

Family

ID=24676595

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903541A HUP9903541A3 (en) 1996-06-20 1997-06-10 Nasal administration of desmopressin

Country Status (24)

Country Link
US (1) US5763398A (hu)
EP (1) EP0921786A1 (hu)
JP (1) JP2000502358A (hu)
KR (1) KR20000016781A (hu)
CN (1) CN1233952A (hu)
AU (1) AU707527B2 (hu)
BR (1) BR9700797A (hu)
CA (1) CA2258552A1 (hu)
CZ (1) CZ420198A3 (hu)
EE (1) EE9800453A (hu)
HU (1) HUP9903541A3 (hu)
IL (1) IL127572A (hu)
LT (1) LT4621B (hu)
LV (1) LV12230B (hu)
NO (1) NO985936L (hu)
NZ (1) NZ333124A (hu)
PL (1) PL330902A1 (hu)
RO (1) RO120170B1 (hu)
RU (1) RU2173559C2 (hu)
SI (1) SI9720040A (hu)
SK (1) SK176998A3 (hu)
TR (1) TR199802596T2 (hu)
UA (1) UA49888C2 (hu)
WO (1) WO1997048379A1 (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
JP5767103B2 (ja) * 2008-05-21 2015-08-19 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US8650937B2 (en) 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
BRPI0923557A2 (pt) * 2008-12-22 2016-01-26 Allergan Inc administração de desmopressina intranasal
ES2929471T3 (es) 2009-06-18 2022-11-29 Acerus Pharmaceuticals Usa Llc Administración segura de desmopresina
US9211377B2 (en) 2009-07-30 2015-12-15 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
FR2954774B1 (fr) * 2009-10-30 2012-01-06 Michelin Soc Tech Methode de preparation d'un melange maitre de caoutchouc naturel et de silice
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
RU2605311C1 (ru) * 2015-07-14 2016-12-20 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ лечения болевого синдрома у больных с дегенеративно-дистрофическими заболеваниями позвоночника

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
PT708657E (pt) * 1993-06-29 2001-11-30 Ferring Bv Composicoes para administracao nasal de desmopressina
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin

Also Published As

Publication number Publication date
AU707527B2 (en) 1999-07-15
WO1997048379A1 (en) 1997-12-24
TR199802596T2 (xx) 1999-03-22
LT4621B (lt) 2000-02-25
NZ333124A (en) 1999-05-28
AU3280297A (en) 1998-01-07
IL127572A0 (en) 1999-10-28
NO985936L (no) 1999-02-16
SI9720040A (sl) 1999-08-31
JP2000502358A (ja) 2000-02-29
IL127572A (en) 2003-04-10
RU2173559C2 (ru) 2001-09-20
EE9800453A (et) 1999-08-16
NO985936D0 (no) 1998-12-17
KR20000016781A (ko) 2000-03-25
UA49888C2 (uk) 2002-10-15
LT98188A (en) 1999-11-25
CA2258552A1 (en) 1997-12-24
LV12230B (en) 1999-06-20
PL330902A1 (en) 1999-06-07
CZ420198A3 (cs) 1999-04-14
BR9700797A (pt) 1998-10-06
EP0921786A1 (en) 1999-06-16
CN1233952A (zh) 1999-11-03
HUP9903541A2 (hu) 2000-04-28
LV12230A (lv) 1999-03-20
US5763398A (en) 1998-06-09
SK176998A3 (en) 1999-05-07
RO120170B1 (ro) 2005-10-28

Similar Documents

Publication Publication Date Title
US5797392C1 (en) Inhaler
HUP9903541A3 (en) Nasal administration of desmopressin
EG21736A (en) Nasal dilator
GB2318737B (en) Improved inhalers
PL327616A1 (en) Inhaler
HUP9901316A3 (en) Inhaler
GB2312379B (en) Improved inhalers
IL122605A0 (en) Inhaler
PL325233A1 (en) Inhaler
PL334447A1 (en) Inhaler
AU135548S (en) Inhaler
AU135120S (en) Inhaler
GB9507133D0 (en) Inhaler
GB9700737D0 (en) Administration of drugs
AU1677095A (en) Oral dosage form of desmopressin (ddavp)
GB9602704D0 (en) Structure of perculator
GB2320900B (en) Inhalers
GB9608255D0 (en) Nasal intubation
HK1020871A (en) Nasal administration of desmopressin
GB2310370B (en) Inhaler carrying aid
CA79609S (en) Nasal inhaler
TW354901U (en) Improvement of respirator
TW312324U (en) Structure of suspension-type nasal spraying device
TW298066U (en) Improved structure of nostril filter
GB9614027D0 (en) Medicinal remedy